Inventor · disambiguated record
Zheng-Yun James Zhan
Also filed as: ZHAN ZHENG · ZHAN ZHENG-YUN · ZHAN ZHENG-YUN JAMES
13 granted patents·6 pending applications·67 citations·filing 1993–2024
88Inventor score
Files withZHAN ZHENG-YUN JAMES10SHANGHAI AB PHARMATECH LTD4ZANNAN SCITECH CO LTD2SCHERING CORP1UNIV NORTHEASTERN1
Top patents by PatentIndex Score
19 records- 0192US8049025B2Recyclable ruthenium catalysts for metathesis reactionsZANNAN SCITECH CO LTD·Filed 2009·Granted Nov 1, 2011·27 cites·21 claims
- 0292US7632772B2Recyclable ruthenium catalysts for metathesis reactionsZHAN ZHENG-YUN JAMES·Filed 2006·Granted Dec 15, 2009·22 cites·28 claims
- 0389US8288576B2Recyclable ruthenium catalysts for metathesis reactionsZHAN ZHENG-YUN JAMES·Filed 2011·Granted Oct 16, 2012·5 cites·18 claims
- 0479US2024383858A1Multi-targeted tyrosine kinase inhibitors effective in antitumor usesSHANGHAI AB PHARMATECH LTD·Filed 2024·Application pending·0 cites
- 0578US2024166606A1Multi-targeted tyrosine kinase inhibitors and their pharmaceutical usesSHANGHAI AB PHARMATECH LTD·Filed 2024·Application pending·0 cites
- 0673US12071408B2Multi-targeted tyrosine kinase inhibitors effective in antitumor usesSHANGHAI AB PHARMATECH LTD·Filed 2022·Granted Aug 27, 2024·0 cites·10 claims
- 0773US11912663B2Multi-targeted tyrosine kinase inhibitors and their pharmaceutical usesSHANGHAI AB PHARMATECH LTD·Filed 2022·Granted Feb 27, 2024·0 cites·8 claims
- 0873US9334291B2Antiviral compounds highly effective as HCV-NS5A inhibitorZHAN ZHENG-YUN JAMES·Filed 2014·Granted May 10, 2016·1 cites·30 claims
- 0971US8962810B2Macrocyclic heterocyclic compound for inhibiting hepatitis C virus and preparation and use thereofZHAN ZHENG-YUN JAMES·Filed 2012·Granted Feb 24, 2015·2 cites·17 claims
- 1069US5349099AProcess for preparing intermediates for the synthesis of antifungal agentsSCHERING CORP·Filed 1993·Granted Sep 20, 1994·10 cites·11 claims
- 1165US2025281854A1Device for Separating Gases from LiquidsZHAN ZHENG·Filed 2024·Application pending·0 cites
- 1260US9820972B2Antiviral compounds highly effective as HCV-NS5A inhibitorZHAN ZHENG-YUN JAMES·Filed 2016·Granted Nov 21, 2017·0 cites·7 claims
- 1355US2023340237A1Liquid hydrogenated nitrile-butadiene rubber, preparation method thereof and use thereofZANNAN SCITECH CO LTD·Filed 2021·Application pending·0 cites
- 1455US2014080984A1Highly active metathesis catalysts selective for romp and rcm reactionsZHAN ZHENG-YUN JAMES·Filed 2013·Application pending·0 cites
- 1551US8815796B2Polyheterocyclic compounds highly potent as HCV inhibitorsZHAN ZHENG-YUN JAMES·Filed 2013·Granted Aug 26, 2014·0 cites·31 claims
- 1649US8592618B2Highly active metathesis catalysts selective for ROMP and RCM reactionsZHAN ZHENG-YUN JAMES·Filed 2010·Granted Nov 26, 2013·0 cites·17 claims
- 1749US2021256383A1Computer-implemented methods and systems for privacy-preserving deep neural network model compressionUNIV NORTHEASTERN·Filed 2021·Application pending·0 cites
- 1845US8653025B2Polyheterocyclic compounds highly potent as HCV inhibitorsZHAN ZHENG-YUN JAMES·Filed 2011·Granted Feb 18, 2014·0 cites·33 claims
- 1942US8633280B2Methods of modifying polymers with highly active and selective metathesis catalystsZHAN ZHENG-YUN JAMES·Filed 2011·Granted Jan 21, 2014·0 cites·20 claims
Join the waitlist — get patent alerts
Get an alert when Zheng-Yun James Zhan files or is granted a new patent.
We store only your email — no account needed. See our privacy policy.
Identity basis: PatentsView inventor disambiguation (2025Q4-odp release). How scoring works →